Chemical and Pharmaceutical Bulletin · 2015 · 19 citations · 14 references
PharmacyMedicinal ChemistryOncologyDrug DesignDrug DiscoveryStructure-activity RelationshipsLigand-based DesignStructure-activity Relationship AnalysisAnticancer ChemotherapyAnticancer Compound ScreeningChemical Structure-activity RelationshipsMedicinal Chemistry ApplicationsStructure - Activity Relationship OptimizationStructure-activity Relationship ModelingX-ray Diffraction AnalysisX-ray Spectral Analysis
A series of sulfur 1,2,4-triazine derivatives were prepared and evaluated as anticancer compounds for two human breast cancer cell lines (MCF-7, MDA-MB-231) with some of them acting as low micromolar inhibitors. Evaluation of the cytotoxicity using a 3-(4,5-dimethylthiazol-2-yl)-3,5-diphenyltetrazolium bromide (MTT) assay, the inhibition of [(3)H]thymidine incorporation into DNA, and collagen synthesis inhibition demonstrated that these products exhibit cytotoxic effects on these breast cancer cell lines in vitro. The most effective were disulfide and sulfenamide compounds with two valence sulfur atoms. A structure-activity relationship study was performed using X-ray analysis and theoretical calculations at an ab initio density functional theory (DFT) level.
14
A short history of<i>SHELX</i>
George M. Sheldrick · Acta Crystallographica Section A Foundations of Crystallography · 2007 · 87.4K citations · Full text
<i>WinGX</i>and<i>ORTEP for Windows</i>: an update
Louis J. Farrugia · Journal of Applied Crystallography · 2012 · 11.8K citations